Article
Dihydromyricetin induces apoptosis and inhibits proliferation in hepatocellular carcinoma cells
9 Jul 2014
Abstract excerpt
Hepatocellular carcinoma (HCC) is a life‑threatening disease that is known to exhibit a poor prognosis. Therefore, it is important to identify an effective drug therapy for the treatment of HCC. Dihydromyricetin (DHM) is a flavonoid compound, isolated from the classical Chinese herb Ampelopsis grossedentata, which exhibits multiple pharmacological activities, including anticancer effects. In this study, the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
